StockData
Cullinan Therapeutics, Inc. logo

Cullinan Therapeutics, Inc. (CGEM) stock

CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$9.28−0.22 (-2.37%)

Close on Nov 17, 2026Market cap $596.89MP/E –Yield –

Cullinan Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cullinan Therapeutics's price to sales ratio was 22.9× on Apr 29, 2022.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 202222.9×–

More Cullinan Therapeutics figures

See a number that looks wrong?